Belite Bio, Inc
Belite Bio, Inc (BLTE) Stock Overview
Explore Belite Bio, Inc’s financial performance, market position, analyst ratings, and future outlook.
Key Financials
Key Financials
Market Cap
6.5B
P/E Ratio
-71.24
EPS (TTM)
$-2.31
ROE
-0.43%
BLTE Stock Analysis & Investment Overview
Our comprehensive AI-powered analysis of Belite Bio, Inc (BLTE) provides investors with deep insights into the stock's performance, growth potential, and market positioning. With a Meyka AI Score of B+, this stock demonstrates moderate investment characteristics based on our advanced machine learning models.
The current technical analysis reveals key indicators including an RSI of 40.68, suggesting the stock is in a neutral condition. Our forecasting models predict significant price movements, with a 12-month target of $139.35.
Key financial metrics showcase the company's fundamental strength, including a P/E ratio of -71.24 and a market capitalization of 6.5B. These metrics, combined with our AI analysis, provide a comprehensive view for both institutional and retail investors.